Many previously published data confirmed the presence of ETS1 mRNA in cancer tissue [2,6,9,13], but we have not found the manuscript describing the association of down-regulation of cytoplasmic expression of the ETS1 protein, miR-203a-3p/miR-204-3p expression, and unfavorable clinicopathological factor occurrence. This evidence concerns the gene ETS1 and cancer.